First Horizon Corporation’s Quest Diagnostics DGX Stock Holding History

First Horizon Corporation’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$75.2K	Buy	355 +199	+128%	+$39.1K	﹤0.01%	598
2026 Q1	$30.6K	Sell	156 -34	-18%	-$6.61K	﹤0.01%	774
2025 Q4	$33K	Buy	190 +18	+10%	+$3.28K	﹤0.01%	808
2025 Q3	$32.8K	Buy	+172	New	+$30.5K	﹤0.01%	715
2021 Q2	$9K	Hold	70	–	–	﹤0.01%	713
2021 Q1	$8K	Buy	70 +4	+6%	+$493	﹤0.01%	729
2020 Q4	$7K	Sell	66 -26	-28%	-$3.17K	﹤0.01%	729
2020 Q3	$10K	Buy	+92	New	+$10.9K	﹤0.01%	613
2013 Q2	$24K	Buy	+400	New	+$23.8K	0.01%	385

Other funds holding DGX

AIM

Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.94% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

ECSS

Eurizon Capital SGR SpA Milan $37.3B AUM

Eastern Bank Boston, Massachusetts $6.53B AUM 30.05% 1-Year Est. Return

CPC

Cookson Peirce & Co Pittsburgh, Pennsylvania $3.04B AUM 94.11% 1-Year Est. Return

WIC

Willis Investment Counsel Gainesville, Georgia $2.1B AUM 24.61% 1-Year Est. Return

AIM

Achmea Investment Management Zeist, Netherlands $4B AUM 31.99% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

First Horizon Corporation's DGX Position: Q2 2026 in Review

First Horizon Corporation increased its Quest Diagnostics (DGX) stake by 128% in Q2 2026, buying an estimated $39.1K and bringing the position to 355 shares worth $75.2K. The position accounts for ﹤0.01% of the portfolio, ranked #598.

First Horizon Corporation first reported a position in DGX in Q2 2013 and has held it in 9 quarters since. 479 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

First Horizon Corporation held 355 shares of Quest Diagnostics worth $75.2K as of Q2 2026.
First Horizon Corporation bought 199 Quest Diagnostics shares in Q2 2026, an estimated $39.1K.
Quest Diagnostics made up ﹤0.01% of First Horizon Corporation's portfolio in Q2 2026, its #598 holding.
First Horizon Corporation first reported a position in Quest Diagnostics in Q2 2013 and has held it in 9 quarters since.
479 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on First Horizon Corporation's 13F filing for Q2 2026, filed 20 Jul 2026.